Boston Scientific: Barclays initiates coverage with equal-weight rating and $48 target
BSX•Barclays initiated coverage of Boston Scientific with an equal-weight rating and a $48 target price.
Related News
Zoom Communications: Yorkville Ives initiates coverage with outperform rating; target price $120
ZM•
Zscaler: TD Cowen raises target price to $230 from $200
ZS•
Glaukos schedules third-quarter 2026 results release, conference call
GKOS•
The Hartford Insurance Group: Mizuho cuts target price to $144 from $154
HIG•
Novartis reports positive Phase III REMODEL-1/-2 data for remibrutinib in relapsing multiple sclerosis
NVS•